Nearly 3 Billion Were at Risk for Malaria in 2009
An estimated 2.85 billion people worldwide were at risk of contracting malaria in 2009, according to a new report published Tuesday in the journal PLos Neglected Tropical Diseases.
An estimated 2.85 billion people worldwide were at risk of contracting malaria in 2009, according to a new report published Tuesday in the journal PLos Neglected Tropical Diseases.
Doctors in London successfully used a genetically engineered version of the herpes virus to treat head and neck cancer in a small clinical trial of 17 patients.
More Americans are getting tested for colon cancer and breast cancer, the U.S. Centers for Disease Control (CDC) recently reported, but the numbers still aren’t high enough.
Researchers in California may have discovered new drug targets to treat an incurable hereditary disease that leads to loss of motor coordination, dementia and death.
Researchers at the University of California San Diego and GlySens Inc. are developing an implantable wireless sensor to continuously monitor blood sugar in diabetes patients, Reuters reports.
Seaside Therapeutics reported encouraging results from the largest randomized study conducted to date in patients with Fragile X syndrome.
The information could allow researchers to observe cellular changes as a patient undergoes cancer treatment, and could aid in the development of new molecular therapeutics for diseases such as cancer.
An experimental drug from Nektar Therapeutics was able to shrink tumors and reduce a cancer biomarker in women with advanced ovarian cancer in a mid-stage study.
A disease that affects a significant number of Americans, that requires extensive and often frustrating lifestyle modifications, and that has no approved pharmaceutical treatment: It’s an enticing opportunity for drug companies.
Copyright © 2025 | WordPress Theme by MH Themes